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Abstract 
Aim: To identify PM2.5 as a risk factor for chronic obstructive pulmonary disease 
(COPD) and coronary heart disease (CHD) respectively, and to explore the magnitude 
of the association of PM2.5 with the coexistence of CHD and COPD, by using the 
combined dataset of 1999-2014 EPA Air Data and 2017 BRFSS SMART data (age 18 
and older).  
Methods: Cross-sectional study was designed to identify the association between 
PM2.5 exposure and COPD and CHD. The PM2.5 exposure values were adapted from 
the county-level EPA Air Data, the yearly mean values of PM2.5 were used to determine 
the association. Characteristics of sex, age, race, health status, and socioeconomic status 
were obtained from the BRFSS SMART data. Binary logistic regressions using 
binary/two-level (“high-level” and “low-level” determined by EPA National Ambient 
Air Quality Standards) PM2.5 exposure values and continuous PM2.5 exposure values 
respectively were applied to identity the association between PM2.5 exposure and 
target health outcomes. 
Results: Adjusted odds ratios (AOR) (with adjustments of sex, race, education, and 
income) between binary PM2.5 and CHD among elderly group (with age equal to or 
older than 65) was 1.074 (P<0.05, 95% CI 1.017-1.134); the same association among 
younger group (with age younger than 65) was not significant. A significant association 
between binary PM2.5 and COPD was observed (for elderly group, AOR=1.129 95% 
CI 1.072-1.188; for younger group, AOR=1.195 95% CI 1.136-1.257). 2448 (1.4%) 
respondents reported that had ever been told have both CHD and COPD, there was a 
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significant association between binary PM2.5 and the coexistence of COPD and CHD 
among the elderly population (AOR=1.168 95% CI 1.054-1.295). Associations between 
continuous PM2.5 (adjusted by per 5 µg/m3 increase) and the outcomes suggested the 
same trend of results. 
Conclusions: The association between PM2.5 and CHD was not as strong as the 
association between PM2.5 and COPD. However, the association between PM2.5 and 
the coexistence of CHD and COPD among elderly population was stronger than the 
associations between PM2.5 and either of them, according to the AOR. These finds may 
help with the diagnosis of CHD within populations that have COPD, especially in high 
PM2.5 exposure areas. Future studies that can determine the temporal sequence of 
association are required to figure out the association between COPD and CHD 
regarding to the PM2.5 exposure. 
 
 
 
 
  
3 
Introduction 
COPD is the current fourth leading cause of death in the world. By 2020, COPD 
will be the third leading cause of death. COPD is a major cause of chronic morbidity 
and mortality around the world (Global Initiative for Chronic Obstructive Lung Disease, 
2018). Back to 1993, (Dockery et al., 1993) conducted a population-based, cross-
sectional studies of metropolitan areas in six US cities to study the effects of air 
pollution on mortality. After adjusting for smoking and other risk factors, including 
occupational exposure to dust, gases, or fumes there was a statistically significant 
associations between fine particles and mortality, they compared the adjusted mortality-
rate of the most polluted cities and the least polluted cities, the rate ratio was 1.26 (95% 
CI, 1.08-1.47). In a cohort study of US veterans regarding to traffic density and 
mortality, PM2.5 had the largest RR among all the individual air quality measures, 
1.118 (95% CI, 1.038-1.203), (Lipfert, Wyzga, Baty, & Miller, 2006). 
COPD is characterized by persist respiratory symptoms and airflow limitation; the 
issues are due to airway and/or alveolar abnormalities that cause a decrease in the ratio 
of forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC); if the ratio is 
lower than 70%, it would be defined as a persist respiratory symptoms and airflow 
limitation, (Sin & Man, 2005). The adverse issues are usually caused by significant 
exposure to noxious particles or gases. Tobacco smoking is characterized as the main 
risk factor of COPD, (Loffredo et al., 2016); besides, the environmental exposure is 
also a risk factor. COPD can be resulted from host factors as well, including genetic 
abnormalities, abnormal lung development and accelerated aging, (Global Initiative for 
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Chronic Obstructive Lung Disease, 2018). 
CHD is also called coronary artery disease (CAD). The buildup of plaque in the 
arteries of the heart can induce a reduction of blood flow to the heart muscle. The main 
symptom is angina (chest pain) which can usually last longer than 10 minutes, and even 
longer than 30 minutes. Other symptoms of CHD include shortness of breath, sleep 
problems, fatigue, lack of energy, (American Heart Association, 2019) Risk factors for 
CHD relate more to health behavior, such as tobacco smoking, inactivity, unhealthy diet, 
high blood pressure, diabetes, overweight and obesity, and host factors like aging and 
family history of heart disease, (Mendis et al., 2011). A study based on BRFSS and EPA 
Air Data illustrated a positive association between PM2.5 and cardiovascular disease 
(CVD), the multivariable-adjusted odds for the multiplicity of CVD outcomes 
increased by 1.32 (95% CI 1.23–1.43) times per 10 mg/m3 increase in PM2.5, (Feng, 
Yang, & Cook, 2012). (Johnson & Parker, 2009) conducted a study based on the 
National Health Interview Survey (NHIS) from 1999 to 2005 and EPA Air Data, there 
was an association between 10mg/m3 increase in PM2.5 exposure and heart disease 
with a small elevated risk (AOR=1.08 95% CI 1.00-1.16).  
A meta-analysis of 110 studies, dated to May 2011 was conducted for PM 2.5 and 
daily mortality and hospital admissions. According to this study, per 10 µg/m3 
increment in PM2.5 increased the risk of death due to COPD by 3.86%; around 2.30% 
increase in the risk of hospital admissions due to COPD among the population with 
ages older than 65 years; this meta-analysis also indicated that per 10 µg/m3 increment 
in PM2.5 could cause 3.36% increase in the risk of death due to CHD; around 2.50% 
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increase in the risk of hospital admissions due to CHD among the population with ages 
older than 65 years, (Atkinson, Kang, Anderson, Mills, & Walton, 2014). A study of the 
association between PM2.5 and cardiovascular hospitalizations indicated that PM2.5 
total mass and PM2.5 road dust were the main contributors to the hospitalization rate, 
(Bell et al., 2013). 
Smoking is the main risk factor for both COPD and CHD. With symptoms of 
simple chronic bronchitis, the risk of death due to coronary events increases 50%. The 
decrease of the ratio FEV1 to FVC increases the risk of a coronary event by 30%. As 
10% decrease in FEV1, all-cause mortality increases 14%, cardiovascular mortality 
increases 28%, non-fatal coronary events increases 20%. Coexistence of 
extrapulmonary comorbidities, such as coronary heart disease, heart failure, ischemic 
heart disease, systemic venous thromboembolism, hypertension, anxiety and 
depression, osteoporosis, metabolic syndrome and diabetes, sleep disturbance, 
influence the prognosis of patients with COPD, (Cavaillès et al., 2013; Global Initiative 
for Chronic Obstructive Lung Disease, 2018). Coexistence of COPD and coronary heart 
disease can not only worsen the prognosis of COPD, but also worsen the prognosis of 
CHD. Coronary heart disease is often unrecognized in COPD, (Cavaillès et al., 2013).  
Several previous studies indicated the associations between PM2.5 and COPD or 
CHD regarding to other health outcomes. (McCormack et al., 2015) conducted a study 
on the effects of indoor PM on COPD among obese and non-obese participants. The 
results showed that obesity modified the effects of indoor PM on COPD respiratory 
outcomes; PM2.5 increases were associated with greater increases in nocturnal 
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symptoms, dyspnea and rescue medication use among obese participants. There are 
studies on the associations between PM2.5 and CHD regarding to hypertension, 
(Johnson & Parker, 2009). This study suggested that a 10 mg/m3 increase in PM2.5 
exposure was associated with an elevated risk of hypertension among non-Hispanic 
white people (AOR=1.10 95% CI 1.04-1.17). 
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Methods 
Individual-Level Data 
Data on COPD, CHD status and individual covariates were obtained from the U.S. 
Behavioral Risk Factor Surveillance System (BRFSS), SMART: City and County 
Survey Data. BRFSS, which is conducted by the Centers for Disease Control and 
Prevention (CDC), is the nation’s premier system of health-related telephone surveys 
that collect state data about U.S. residents (18+ years old and non-institutionalized) 
regarding their health-related risk behaviors, chronic health conditions, and use of 
preventive services. BRFSS now collects data in all 50 states as well as the District of 
Columbia and three U.S. territories. The survey is based on Random Digit Dialing 
(RDD) techniques on both landlines and cell phones and a standardized core 
questionnaire, as well as optional modules, and state-added questions. Since 2005, 
BRFSS began to monitor cardiovascular disease (CVD) status among U.S. adults. In 
the section of CVD, angina or coronary heart disease (CHD) status is collected by the 
question “(Ever told) you had angina or coronary heart disease?”, (Centers for Disease 
Control and Prevention, 2019). 
BRFSS data are state-level, for this study, area-level data are required to correspond 
the city-level ambient air pollution data. The SMART project of BRFSS produces data 
set with localized health information for metropolitan and micropolitan statistical areas 
(MMSAs) which have geographic subdivisions designated by the U. S. Office of 
Management and Budget and used by the U. S. Census Bureau as of June 2003. For the 
2017 BRFSS combined landline telephone and cellular telephone data that have 500 or 
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more respondents, MMSAs would be selected in the SMART BRFSS data, (Centers for 
Disease Control and Prevention, 2017a). 
The general concept of a metropolitan or micropolitan statistical area is that of a 
core area containing a substantial population nucleus, together with adjacent 
communities and all having a high degree of economic and social integration. 
Metropolitan statistical areas are the groups of counties that contain at least one 
urbanized area of 50,000 or more inhabitants; micropolitan statistical areas are the 
groups of counties that contain at least one urban cluster of at least 10,000 but less than 
50,000 inhabitants; metropolitan divisions are smaller groups of counties within a 
metropolitan statistical area of 2.5 million or more inhabitants, (U.S. Census Bureau, 
2019) 
This study applied the BRFSS SMART data set of 2017. There were 136 MMSAs 
selected in the data set; 230875 respondents participated in this SMART project. 
167032 (72.35%) respondents were non-Hispanic white; 23484 (10.17%) respondents 
were non-Hispanic black; 22022 (9.54%) respondents were Hispanic; except for 4799 
(2.08%) invalid respondents, the other race had respondents of 13538 (5.86%). 
Ambient air pollution data 
Particulate Matter (PM) is defined as the term for a mixture of solid particles and 
liquid droplets found in the air. PM2.5 are fine inhalable particles, with aerodynamic 
diameters of 2.5 micrometers or less, (U.S. Environmental Protection Agency, 2018). 
Concentrations of PM2.5 were extracted primarily from the Air Quality System (AQS) 
database, also called Air Data, which is conducted by U.S. Environmental Protection 
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Agency (EPA).  
The years of Air Data ranged from 1999 to 2014; and there was no systematic 
sampling of PM2.5 before 1999. The dataset was national-wide and in counties or core 
based statistical areas (CBSA) level with exceptional events. Exceptional events, such 
as high winds and wildfire, were flagged by states. The dataset contained values of 24-
hr mean of PM2.5 concentrations from 615 monitoring sites. 24-hr mean of PM2.5 was 
the Weighted Annual Mean by calendar quarter for the year, (U.S. Environmental 
Protection Agency, 1999-2014). The monitoring sites with at least 50% of observations 
(percent of observations calculated as the ratio of valid years for the year of 1999 to 
2014) were referred to provide ambient air pollution data for PM2.5 (total 343 sites). 
The yearly mean level values of PM2.5 mean was calculated. (Table 1) 
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Statistical Analysis 
Valid number of respondents in the 2017 BRFSS SMART survey was 230,875; 
the respondents were above the age of 18 years and lived in the metropolitan or 
micropolitan statistical areas of the U.S. Valid number of air monitoring sites was 343 
in the U.S.  
Core based statistical areas (CBSA) consists of metropolitan statistical areas and 
micropolitan statistical areas, so, CBSA and MMSA represent the same locating 
strategy. The BRFSS SMART data and the EPA Air Data were merged by the 
common variable, CBSA (also known as MMSA). The number of monitoring sites in 
the overlap of the two datasets sorted by statistical areas was 106. 175,328 (76.0%) 
respondents lived in these 106 areas and were selected for the statistical analysis. 
Binary logistic regression was applied to obtain the model and the adjusted odds ratio. 
For statistical analysis of PM2.5, the mean values were used as both a binary variable 
and a continuous variable separately. Because these two types are common in the 
previous studies, so that we can compare the results to prior results by setting PM2.5 
as both binary variable and continuous variable. When considered as a binary 
variable, the mean values of PM2.5 was defined into two levels of exposure. 
According to EPA National Ambient Air Quality Standards (NAAQS), the primary 
standard for PM2.5 is 12 µg/m3 which is an annual arithmetic mean that is averaged 
over 3 years. The primary standards are set to protect public health. 12 µg/m3 was 
used as the cut point. According to EPA’s rounding rule for annual values, exposures 
which were equal to or below that 12.04 µg/m3 were defined as “low-exposure”, 
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otherwise, the exposures were defined as “high-exposure”. The continuous mean 
values of PM2.5 were used to calculate adjusted odds ratios by per 5 µg/m3 PM2.5 
exposure increase. 
Variables of sex, age above 65 or not, COPD and CHD status, smoking status, 
and the education levels were used in as the original coding methods. Variable of race 
was classified into four catalog: non-Hispanic White, non-Hispanic Black, Hispanic, 
and other races; variable of obese was calculated by BMI values (BMI greater than or 
equal to 30 was classified as obese); women with hypertension only during pregnancy 
were classified as “no hypertension” (also applicable in diabetes); the number of “not 
sure and missing” in the variable of income was classified as a category (unknown) in 
the regression because it took 17% of the number of the entire study sample. All the 
unknown/unsure and missing values were treated as missing values (classified as 
“Unknown”) in the regression, expect for the income values.  
The respondents were stratified into two groups by age (equal to or older than 65, 
and younger than 65), due to the large portion of elderly population, and strong 
associations between age and the outcomes; also, age may be a confounder for some 
of the covariables. Logistic regressions for three outcomes were conducted by using 
binary PM2.5 values and continuous PM2.5 values, respectively. Each logistic 
regression was basically adjusted for sex, race, education levels, and income levels. 
Variables of hypertension, obese, diabetes, and smoking status were included 
individually in different logistic regressions. 
SAS (v9.4; SAS Institute Inc., Cary, NC, USA) was used to merge the EPA Air 
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Data and the BRFSS SMART data. Variables of CBSA and yearly 24-h PM2.5 mean 
values in the EPA Air Data and variables in the BRFSS SMART data of annual 
sequence number (SEQNO), MMSANAME, “(Ever told) you had angina or coronary 
heart disease?” (CVDCRHD4) “(Ever told) you have chronic obstructive pulmonary 
disease, C.O.P.D., emphysema or chronic bronchitis?” (CHCCOPD1), whether the 
age is older than 65 (_AGE65YR), sex (SEX), race (_RACE), hypertension 
(BPHIGH4), diabetes (DIABETE3), whether BMI is greater than 30 (_BMI5), 
education levels (EDUCA), income levels (_INCOMG), and smoking status 
(_SMOKER3) were output to the merged dataset. SPSS (IBM Corp. Released 2017. 
IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp.) was used 
to output descriptive statistics and frequency distributions; to calculate the crude 
bivariate odds ratios among the variables; and to compute the logistic regressions. 
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Results 
Among the 175,328 respondents, 44.1% were male (55.8% female); 33.7% were 
equal to or older than 65; non-Hispanic White took the largest composition of 73.9%, 
followed by Hispanic (9.6%) and non-Hispanic Black (9.0%). 7.8% respondents 
reported being told have COPD (47.6% of these respondents lived in “high” exposure 
areas); 5.3% respondents reported being told have CHD (45.5% of these respondents 
lived in “high” exposure areas); and 1.4% respondents reported “Yes” for both CHD 
and COPD. (Table 2) 
When age was considered as a covariable and had not been stratified, crude odds 
ratios between age and the outcomes were 4.512 (95% CI 4.314-4.719), 2.312 (95% 
CI 2.232-2.395), 3.684 (95% CI 3.387-4.007), for COPD, CHD, and the coexistence, 
respectively. The prevalence of COPD in elderly group and younger group were 
12.2% and 5.7%, respectively; the prevalence of CHD in elderly group and younger 
group were 10.8% and 2.6%, respectively; the prevalence of COPD in elderly group 
and younger group were 2.7% and 0.7%, respectively. 
Association between PM2.5 and COPD 
Binary PM2.5. In the logistic regression in which PM2.5 values were used as a 
binary variable, the crude odds ratio between PM2.5 and COPD was 1.150 (95% CI 
1.094-1.208) in the elderly group. When adjusted for variables of age, sex, race, 
education, and income, the AOR between PM2.5 and COPD was 1.129 (95% CI 
1.072-1.188); adjustments for hypertension, obese, diabetes, and smoking status in 
additional models did not show magnitude differences. Among the younger group, 
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crude OR and AOR were higher than those among the elderly group, 1.195 (95% CI 
1.136-1.257) and 1.174 (95% CI 1.113-1.238), respectively. Also, adjustments for 
hypertension, obese, diabetes, and smoking status in additional models did not show 
magnitude differences. 
Continuous PM2.5. In the logistic regression in which PM2.5 values were used as a 
continuous variable, the AOR in the elderly group was 1.191 (95% CI 1.133-1.246) 
when included age, sex, race, education, and income in the model; variables of 
hypertension, obese, diabetes, and smoking status did not affect the results. In the 
younger group, the AOR was lower than those in the elderly group, 1.168 (95% CI 
1.111-1.228). The additional adjustments for hypertension, obese, diabetes, and 
smoking status made no differences to the results. (Table 3) 
Association between PM2.5 and CHD 
Binary PM2.5. Crude OR between binary PM2.5 and CHD among the elderly group 
was 1.079 (95% CI 1.024-1.137). The adjusted model for age, sex, race, education, 
and income suggested that odds increased 7.4% in high PM2.5 exposure area; 
additional model adjustments for hypertension, obese, diabetes, and smoking status 
did not distinctly change the results. However, among the younger group, PM2.5 
mean values were no longer a significant risk factor. 
Continuous PM2.5. In the logistic regression model using continuous PM2.5 values, 
elevated odds for an increase of 5 µg/m3 PM2.5 exposure were about 7.8% 
(AOR=1.078 95% CI 1.025-1.133). Additional model adjustments for hypertension, 
obese, diabetes, and smoking status did not distinctly change the results. Among the 
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younger group, the associations between PM2.5 and the outcomes were no longer 
significant. (Table 4) 
Association between PM2.5 and both CHD and COPD 
Among the respondents that reported being told ever had COPD and the respondents 
that reported being told ever had CHD, 2448 (1.4%) respondents reported “Yes” in 
both questions; 1584 (64.7% of these respondents) respondents were belong to the 
elderly group. 
Binary PM2.5. Among the elderly group, the crude odds ratio was 1.183 (95% CI 
1.071-1.307). AOR for basic variables of sex, race, education levels, and income 
levels was 1.168 (95% CI 1.054-1.295). Adjustments for the additional variables of 
hypertension, obese, diabetes, and smoking status made no obvious differences. 
Among the younger group, PM2.5 did not have associations with the outcome of the 
coexistence of COPD and CHD. 
Continuous PM2.5. Among elderly group, AOR for basic variables of sex, race, 
education levels, and income levels was 1.228 (95% CI 1.116-1.357). Additional 
models included variables of hypertension, obese, diabetes, and smoking status did 
not affect the AOR obviously. Among younger group, the basic AOR for variables of 
sex, race, education levels, and income levels was 1.168 (95% CI 1.030-1.323). 
Additional adjusted models for hypertension and diabetes indicated that PM2.5 was 
not a significant risk factor for the coexistence of COPD and CHD; however, adjusted 
models for obese and smoking status suggested significant associations between 
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PM2.5 and the coexistence of COPD and CHD, (AOR=1.168 95% CI 1.030-1.336, 
AOR=1.156 95% CI 1.020-1.323, respectively). (Table 5) 
Associations between the covariables and the outcomes 
Adjusted OR for variables of sex, race, education levels, and income levels were 
obtained from the logistic regressions involved with these variables. Adjusted OR for 
hypertension, obese, diabetes, and smoking status were obtained from the separate 
logistic regressions included each of these variables respectively.  
Sex had significant associations with CHD among both elderly group and younger 
group (male as reference, OR=2.191 95% CI 2.074-2.315, OR=1.543 95% CI 1.431-
1.663, respectively); also, sex had a significant associations with the coexistence of 
COPD and CHD among the elderly group (OR=1.663 95% CI 1.498-1.846). Lower 
education levels and income levels were involved with higher odds ratios; overall, the 
odds ratios among the younger group were correspondingly higher than the odds 
ratios among the elderly group. Variables of specific characteristics of hypertension, 
obese, diabetes, and smoking status had significant associations with the three 
outcomes among the two age stratified groups. (Table 6 & 7) 
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Discussion 
The weighting methodology of 2017 BRFSS is comprised of two sections: design 
weight and raking. Design weighting is conducted to reduce bias due to unequal 
probability of selection; raking is used to adjust for demographic differences between 
those persons who are sampled and the population that they represent.  
The weight of each geographic stratum, the number of landline phones within a 
household, and the number of adults who use those phones are considered when 
calculating design weights. In addition, 2017 BRFSS also includes cellular telephone 
respondents, for the respondents use both cell phone and landline telephone, an 
adjustment to the design weights to account for the overlapping sample frames has 
been used. The combined landline and cell phone design weight has been truncated 
based on quartiles prior to raking. So that to prevent any adults in a state from 
carrying extremely large weights into the raking, and to prevent any adults from 
having extremely small design weights. Nine state level margins and allows up to 
eight additional margins are used to adjust sub-state populations within the raking; 
four additional margins if a county has at least 500 interviews available, and four 
additional margins if multiple regions have been defined for a state and each region 
has at least 500 interviews, (Centers for Disease Control and Prevention, 2017b). As a 
telephone-based survey, BRFSS may call recall bias due to the self-reported 
information, in addition, persons without a telephone or a cell phone are not included; 
BRFSS does not address geographic and social disparities, so the socioeconomic 
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status from BRFSS do not represent the national status, (Ali H. Mokdad, 2003; 
Institute of Medicine (US) Committee on a National Surveillance System for 
Cardiovascular and Select Chronic Diseases, 2011). 
The percentages of the elderly group with the three outcomes were 52.7% (for 
COPD), 68.0% (for CHD), and 65.2% (for coexistence of COPD and CHD). The odds 
ratios had not been changed obviously when stratified by age, and no evidence that 
indicates the relationship between PM2.5 exposure and age, so, there was no 
confounding by age. 
It suggested that high level PM2.5 or a 5 µg/m3 increase of PM2.5 could increase 
the odds of COPD by 10-20% among both elderly group and younger group. (Liu et 
al., 2017) reported the strong association between PM2.5 exposure and COPD, 
OR=2.416 95% CI 1.417-4.118 with PM2.5 level at >35 and ≤75 µg/m3, OR=2.530 
95% CI 1.280-5.001 with PM2.5 level at >75 µg/m3.  However, Liu’s study was 
conducted in a province of China in which there had a relatively high PM2.5 
concentration, thus the PM2.5 cut point(s) was higher than this study and PM2.5 had 
more classification levels, which provided more beneficial PM2.5 distribution. The 
EPA air monitoring sites which were not in the metropolitan and micropolitan 
statistical areas were not included in this study. Also, when setting cut points for the 
exposure, non-differential misclassification may be brought to this study; the 
exposure used in this study is from ambient air, so technically, the exposures had no 
difference between the populations who had or not had the outcomes. 
19 
For CHD, PM2.5 had no significant associations with the outcomes in the 
younger group. Compared with the elderly group, covariables of education and 
income had stronger association with the outcomes in the younger group. Socio-
economic variables had been proved that have associations with CVD (Psaltopoulou 
et al., 2017), according to a recent study about the associations among socioeconomic 
variables, pollution levels, and self-reported histories of asthma, stroke, and heart 
attack in the U.S., higher income levels were associated with lower PM2.5; when 
income levels were included as a predictor, PM2.5 would not have significant 
association with heart attack. (Cox, 2017) In this study, higher income levels were 
associated with the three outcomes, especially in the younger group in which income 
levels had stronger associations with the three outcomes than the elderly group; in the 
younger group, income levels had stronger associations with the coexistence outcome. 
Thus, income may affect the association between PM2.5 and CHD in this study. In 
addition, income had stronger association with the coexistence of COPD and CHD in 
both age groups. 
Smoking is a risk factor for COPD, in this study, current heavy smoker had the 
strongest association with COPD in both age groups, however, when considering 
smoking as predictor for CHD, former smoker had the strongest association with 
CHD in both age groups; so we can assume that smoking may cause a long-term 
effect on cardiovascular; and the association between smoking and the coexistence of 
COPD and CHD was not stronger than the associations with each outcome.  
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In the elderly group, the associations between PM2.5 and the coexistence of 
COPD and CHD were stronger than the associations with each outcome separately 
when adjusted for hypertension, obese, diabetes, and smoking status, respectively.  
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Limitations 
The ambient air pollution data was collected from monitoring sites in the 
metropolitan and micropolitan statistical areas where had a high degree of social and 
economic integration. In this study, 40.2% of the respondents had college or high 
education level, 42.9% of the respondents were in income level of $50,000 or more. 
According to previous studies, people with the high social degree and economic 
integration were more likely to answer and finish the telephone survey. Income levels 
may confounding the association between PM2.5 and CHD (Cox, 2017), so future 
studies should consider income as a stratified variable, especially for younger 
population. 
Regional disparity of PM2.5 was not considered due to the data source, because 
the distributions of the air monitoring sites were not concentrated enough to reflect 
the air quality in one statistical area. The study of (Johnson & Parker, 2009) used 
annual air quality estimates that were averaged from monitors within 20 miles of the 
respondent’s residential block group; this method can be applied in the future study to 
control the underestimates or overestimates caused by inaccurate PM2.5 in a 
relatively large area. In addition, occupational exposure also relates to PM2.5 
exposure. The sources of PM2.5 have a broad range, including incomplete 
combustion, automobile emissions, dust, cooking, and chemical reactions in the 
atmosphere, etc. For further studies of PM 2.5 sources, personal monitoring can be 
applied for specific situations, such as occupational exposures and extreme high 
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ambient exposure, (Moore et al., 2016). Apart from the sources of PM2.5, the 
accumulation of PM2.5 also relates to geography and meteorology. A study from 
Korea indicated that climate factors also have effects on the development and severity 
of respiratory diseases. With the decrease of relative humidity, the effect of PM on 
respiratory diseases would be increased, (Jo et al., 2017). 
There is an estimated 25-45% of patients with COPD are non-smokers (Salvi & 
Barnes, 2009), since smoking can affect both PM2.5 exposure and the outcomes, thus, 
smoking may be a confounder for the associations between PM2.5 and the outcomes; 
future studies can be conducted with stratification of smoking status. 
There is not enough epidemiology studies of the coexistence of COPD and CHD; 
for now, the link between COPD and CHD has been found that is independent of any 
other confounding coronary risk factors, such as smoking status, cholesterol, systemic 
hypertension and BMI (Sin & Man, 2005). However, there were strong associations 
between PM2.5 and hypertension, BMI, and smoking, so, the regression models in 
this study could not indicate the associations among the other health outcomes (e.g., 
hypertension, obese, and smoking) and the coexistence of COPD and CHD properly. 
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Conclusions 
The findings in this study indicate that among the elderly population with ages that 
are equal to or greater than 65, PM2.5 is a risk factor for COPD, CHD, and the 
coexistence of COPD and CHD which has a magnitude with association of PM2.5. But 
the association between PM2.5 and CHD was not as strong as the association between 
PM2.5 and COPD.  
These finds may help with the diagnosis of CHD within the populations with 
COPD, especially in high PM2.5 exposure areas. Future studies that can determine the 
temporal sequence of association are required to figure out the association between 
COPD, CHD, and the PM2.5 exposure. 
For the areas where have complex topography and the areas where have more 
concentrated industries and mining, more monitoring sites are required to measure more 
representative PM2.5 values. If possible, BFRSS may be set for specific areas regarding 
to pollutions to provide evidence for pollution-related adverse health outcomes. 
 
 
 
 
  
24 
Acknowledgements 
I would like to extend thanks to the many people who have helped me a lot 
during recent months. Special mention goes to my enthusiastic Chair, Dr. Browning. 
He always gave me encouragement and made confident on my project. Without the 
help of Dr. Browning, I would be in a hard situation with the study design and 
statistical analysis. I also want to thank my committee members, Dr. Christian and Dr. 
Huang. Young and experienced Dr. Christian provided me clear thoughts on the 
limitations of the data sources and my project. Dr. Huang, an excellent biostatistician 
and SAS programmer, guided my data management and aroused my interest on 
biostatistics. 
Also, I want to thank my grandmother, an 87-year-old lady with atherosclerosis 
and COPD, who inspired my life and my project topic.  
25 
Table 1. Distributions of PM2.5, 1999–2014 from 106 sites in contiguous U.S. region. 
  
Number of 
Monitoring 
Sites 
 Yearly Mean Levels (μg/m3) 
  
Mean 25% Q1 50% Median EPA NAAQS 
(Primary) a 
75% Q3 100% Max Interquartile 
Range 
PM2.5 
Mean 
106 11.9 9.8 11.4 12.0 14.2 20.5 4.4 
 
a. EPA regulates particulate matter in primary level and secondary level. Primary standards set limits to protect public health, 
including the health of "sensitive" populations such as asthmatics, children, and the elderly. Secondary standards set limits 
to protect public welfare, including protection against decreased visibility, damage to animals, crops, vegetation, and 
buildings 
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Table 2. Characteristics of sample.  
N % of Total 
Sex 
  
Male 77311 44.1% 
Female 97899 55.8% 
Unknown a 118 0.1% 
   
Age 
  
>=65 59041 33.7% 
<65 113765 64.9% 
Unknown a 2522 1.4% 
   
Race 
  
Non-Hispanic white 129588 73.9% 
Non-Hispanic black 15831 9.0% 
Hispanic 16875 9.6% 
Other 9635 5.5% 
Unknown a 3399 1.9% 
   
Hypertension 
  
Yes 69928 39.9% 
No 104838 59.8% 
Unknown a 562 0.3% 
   
Obese 
  
BMI>=30 48948 27.9% 
BMI<30 111857 63.8% 
Unknown a 14523 8.3% 
   
Diabetes 
  
Yes 25619 14.6% 
No 149415 85.2% 
Unknown a 294 0.2% 
   
Education 
  
Less than high school 
or GED 
11318 6.5% 
High school graduate 43737 24.9% 
Some college or 
technical school 
49095 28.0% 
College and higher 
education 
70501 40.2% 
Unknown a 677 0.4% 
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Income   
Less than $15,000 13010 7.4% 
$15,000 to less than 
$25,000 
22444 12.8% 
$25,000 to less than 
$35,000 
14647 8.4% 
$35,000 to less than 
$50,000 
20411 11.6% 
$50,000 or more 75198 42.9% 
Unknown b 29618 16.9%    
Smoking 
  
Heavy Smoker 16104 9.2% 
Light Smoker 7123 4.1% 
Former Smoker 46746 26.7% 
Never 97840 55.8% 
Unknown a 
 
CHD 
Yes 
No 
Unknown a 
 
COPD 
Yes 
No 
Unknown a 
 
CHD and COPD 
Yes 
No 
Unknown a 
7515 
 
 
9347 
164620 
1361 
 
 
13671 
160840 
817 
 
 
2448 
172880 
237 
4.3% 
 
 
5.3% 
93.9% 
0.8% 
 
 
7.8% 
91.7% 
0.5% 
 
 
1.4% 
98.6% 
0.1%  
   
a. “Unknown” was identified as missing values and not included in the adjusted models 
b. “Unknown” of variable of income was included as a catalog in the adjusted models 
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Table 3. Crude and adjusted odds ratios (OR) and 95% confidence interval (CI) for 
associations between PM2.5 and COPD, stratified by age. 
 
>=65 years 
Binary PM2.5 
95% Confidence Interval  95% Confidence Interval 
 Lower Upper Continuous PM2.5 Lower Upper 
Crude OR 1.150 1.094 1.208 - - - 
Adjusted OR a 1.129  1.072  1.188  1.191b  1.133  1.246  
&Hypertension 1.118 1.062 1.177 1.179 b  1.122  1.234  
&Obese 1.127 1.069 1.189 1.179 b  1.122  1.240  
&Diabetes 1.121 1.065 1.181 1.179 b  1.127  1.240  
&Smoking  1.137 1.078 1.200 1.174 b  1.116  1.234  
       
<65 years       
Crude OR 1.195 1.136 1.257 - - - 
Adjusted OR a 1.174  1.113  1.238  1.168 b  1.111  1.228  
&Hypertension 1.148 1.088 1.211 1.145 b  1.094  1.203  
&Obese 1.162 1.100 1.228 1.162 b  1.105  1.221  
&Diabetes 1.152 1.092 1.216 1.150 b  1.094  1.203  
&Smoking  1.163 1.100 1.228 1.156 b  1.100  1.215  
 
a. Adjusted for: sex, race, education level, and income level 
b. Adjusted by per 5 μg/m3 PM2.5 increase 
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Table 4. Crude and adjusted odds ratios (OR) and 95% confidence interval (CI) for 
associations between PM2.5 and CHD, stratified by age. 
 
>=65 years 
Binary PM2.5 
95% Confidence Interval  95% Confidence Interval 
 Lower Upper Continuous PM2.5 Lower Upper 
Crude OR 1.079 1.024 1.137 - - - 
Adjusted OR a 1.074 1.017 1.134 1.078 b  1.025  1.133  
&Hypertension 1.058 1.001 1.117 1.062 b  1.010  1.116  
&Obese 1.087 1.028 1.149 1.089 b  1.036  1.145  
&Diabetes 1.060 1.004 1.120 1.067 b  1.015  1.122  
&Smoking  1.083 1.025 1.145 1.083 b  1.030  1.139  
       
<65 years       
Crude OR 1.041 0.968 1.121 - - - 
Adjusted OR a 1.027 0.953 1.108 1.010 b  0.946  1.078  
&Hypertension 0.991 0.918 1.070 0.985 b  0.923  1.057  
&Obese 1.018 0.942 1.100 1.015 b  0.951  1.089  
&Diabetes 0.993 0.920 1.071 0.980 b  0.914  1.046  
&Smoking  1.031 0.954 1.113 1.010 b  0.942  1.078  
 
a. Adjusted for: sex, race, education level, and income level 
b. Adjusted by per 5 μg/m3 PM2.5 increase 
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Table 5. Crude and adjusted odds ratios (OR) and 95% confidence interval (CI) for 
associations between PM2.5 and the coexistence of COPD and CHD, stratified by age. 
 
>=65 years 
Binary PM2.5 
95% Confidence Interval  95% Confidence Interval 
 Lower Upper Continuous PM2.5 Lower Upper 
Crude OR 1.183 1.071 1.307 - - - 
Adjusted OR a 1.168 1.054 1.295 1.228b 1.116  1.357  
&Hypertension 1.143 1.031 1.268 1.209 b  1.100  1.330  
&Obese 1.177 1.059 1.309 1.240 b  1.122  1.370  
&Diabetes 1.149 1.036 1.274 1.215 b  1.100  1.336  
&Smoking  1.182 1.063 1.313 1.228 b  1.111  1.350  
       
<65 years       
Crude OR 1.122 0.979 1.285 - - - 
Adjusted OR a 1.070 0.930 1.231 1.168 b  1.030  1.323  
&Hypertension 1.013 0.880 1.168 1.116 b  0.985  1.271  
&Obese 1.059 0.916 1.223 1.168 b  1.030  1.336  
&Diabetes 1.029 0.892 1.185 1.127 b  0.995  1.284  
&Smoking  1.069 0.927 1.234 1.156 b  1.020  1.323  
 
a. Adjusted for: sex, race, education level, and income level 
b. Adjusted by per 5 μg/m3 PM2.5 increase 
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Table 6. Adjusted odds ratios (OR) and 95% confidence interval (CI) for associations between 
covariables and outcomes among respondents who are equal to or older than 65 years old. 
 
a. Adjusted odds ratios are obtained from the logistic regressions with variables of sex, race, education levels, and income levels 
b. Adjusted odds ratios are obtained from the separate logistic regressions with variables of sex, race, education levels, income 
levels, and each specific characteristic respectively 
 COPD CHD CHD and COPD 
 Adjusted 
OR 
95% Confidence 
Interval 
Adjusted 
OR 
95% Confidence 
Interval 
Adjusted 
OR 
95% Confidence 
Interval 
  Lower Upper Lower Upper Lower Upper 
Sex a 
Male 
Female 
 
ref 
1.045  
 
 
0.990  
 
 
1.102  
 
ref 
2.191  
 
 
2.074  
 
 
2.315  
 
ref 
1.663  
 
 
1.498  
 
 
1.846  
Race a          
White, non-Hispanic ref   ref   ref   
Black, non-Hispanic 0.788  0.716  0.868  0.905  0.816  1.004  1.523  1.217  1.905  
Hispanic 0.392  0.339  0.455  0.645  0.559  0.744  0.455  0.343  0.604  
Others 1.162  1.022  1.323  1.021  0.884  1.178  0.874  0.728  1.051  
Education a          
College and higher 
education 
ref   ref   ref   
Some college or 
technical school 
1.521  1.418  1.631  1.291  1.204  1.384  1.782  1.539  2.064  
High school graduate 1.673  1.559  1.795  1.258  1.169  1.353  1.870  1.612  2.169  
Less than high school or 
GED 
2.329  2.103  2.579  1.515  1.353  1.697  2.699  2.220  3.282  
Income a          
$50,000 or more ref   ref   ref   
$35,000 to less than 
$50,000 
1.523  1.395  1.662  1.136  1.040  1.241  1.348  1.120  1.622  
$25,000 to less than 
$35,000 
1.606  1.461  1.765  1.256  1.141  1.384  1.563  1.289  1.896  
$15,000 to less than 
$25,000 
2.091  1.924  2.273  1.459  1.338  1.591  2.143  1.814  2.532  
Less than $15,000 3.104  2.805  3.434  1.704  1.521  1.909  3.418  2.826  4.135  
Missing 1.363  1.256  1.478  1.117  1.029  1.213  1.274  1.072  1.514  
Hypertension b 1.521  1.439  1.609  2.593  2.431  2.766  2.819  2.466  3.222  
Obese b 1.262  1.193  1.335  1.401  1.322  1.485  1.717  1.543  1.910  
Diabetes b 1.393  1.316  1.475  2.237  2.113  2.368  2.430  2.189  2.698  
Smoking b          
Non-smoker ref   ref   ref   
Former smoker 3.495  3.282  3.721  1.485  1.401  1.573  2.756  2.431  3.125  
Current light smoker 5.476  4.783  6.269  1.351  1.139  1.602  4.447  3.506  5.640  
Current heavy smoker 6.571  5.996  7.202  1.026  0.908  1.158  3.231  2.685  3.889  
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Table 7. Adjusted odds ratios (OR) and 95% confidence interval (CI) for associations between 
covariables and outcomes among respondents who are younger than 65 years old. 
 
a. Adjusted odds ratios are obtained from the logistic regressions with variables of sex, race, education levels, and income levels 
b. Adjusted odds ratios are obtained from the separate logistic regressions with variables of sex, race, education levels, income 
levels, and each specific characteristic respectively 
 COPD CHD CHD and COPD 
 Adjusted 
OR 
95% Confidence 
Interval 
Adjusted 
OR 
95% Confidence 
Interval 
Adjusted 
OR 
95% Confidence 
Interval 
  Lower Upper Lower Upper Lower Upper 
Sex a 
Male 
Female 
 
ref 
0.714  
 
 
0.676  
 
 
0.754  
 
ref 
1.543  
 
 
1.431  
 
 
1.663  
 
ref 
1.031  
 
 
0.897  
 
 
1.186  
Race a          
White, non-Hispanic ref   ref   ref   
Black, non-Hispanic 0.650  0.597  0.707  0.806  0.712  0.911  0.604  0.484  0.756  
Hispanic 0.262  0.236  0.290  0.517  0.454  0.588  0.206  0.154  0.277  
Others 0.891  0.805  0.985  1.005  0.874  1.155  1.140  0.905  1.435  
Education a          
College and higher 
education 
ref   ref   ref   
Some college or 
technical school 
1.983  1.837  2.141  1.451  1.313  1.604  2.386  1.899  3.000  
High school graduate 2.485  2.300  2.685  1.443  1.300  1.602  2.750  2.187  3.458  
Less than high school or 
GED 
4.125  3.727  4.565  2.038  1.765  2.353  4.836  3.702  6.319  
Income a          
$50,000 or more ref   ref   ref   
$35,000 to less than 
$50,000 
1.864  1.691  2.056  1.357  1.182  1.558  2.033  1.495  2.763  
$25,000 to less than 
$35,000 
2.286  2.057  2.539  1.534  1.314  1.792  2.665  1.937  3.669  
$15,000 to less than 
$25,000 
3.596  3.309  3.907  2.653  2.366  2.976  5.793  4.570  7.343  
Less than $15,000 5.864  5.383  6.388  3.851  3.416  4.340  10.289  8.137  13.010  
Missing 2.109  1.931  2.303  1.612  1.426  1.822  3.034  2.343  3.929  
Hypertension b 2.725  2.582  2.875  6.495  5.967  7.071  7.600  6.398  9.027  
Obese b 1.545  1.462  1.633  1.896  1.755  2.048  2.137  1.851  2.467  
Diabetes b 2.572  2.413  2.741  4.929  4.549  5.340  5.334  4.622  6.157  
Smoking b          
Non-smoker ref   ref   ref   
Former smoker 3.327  3.096  3.575  2.463  2.250  2.696  4.610  3.774  5.631  
Current light smoker 3.897  3.527  4.306  1.875  1.616  2.175  4.127  3.169  5.375  
Current heavy smoker 5.163  4.794  5.561  1.842  1.646  2.061  4.484  3.632  5.537  
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